Paediatric bipolar disorder: international comparisons of hospital discharge rates 2000-2010

Joe Clacey1, Michael Goldacre2, Anthony James3

  • 1, BM, BCh BA (Hons), Highfield Unit, Warneford Hospital, Oxford.

Bjpsych Open
|October 6, 2016
PubMed

Insights

Paediatric bipolar disorder discharge rates vary significantly worldwide, with the USA showing substantially higher rates than other developed nations. This suggests potential differences in diagnostic practices for child bipolar disorder.

Area of Science:

  • Child and Adolescent Psychiatry
  • Global Health Epidemiology
  • Mental Health Services Research

Background:

  • Diagnosis and prevalence of paediatric bipolar disorder are subjects of ongoing international debate.
  • Estimates of paediatric bipolar disorder vary considerably across different countries, highlighting a need for comparative analysis.

Purpose of the Study:

  • To compare international hospital discharge rates for paediatric bipolar disorder.
  • To contrast these rates with those of all other psychiatric diagnoses in children and adolescents.

Main Methods:

  • Utilized national datasets from England, Australia, New Zealand, the USA, and Germany.
  • Analyzed data spanning the years 2000 to 2010.
  • Focused on hospital discharge rates for individuals under 20 years of age.

Main Results:

  • Discharge rates per 100,000 population for paediatric bipolar disorder (under 20) were: USA 95.6, Australia 11.7, New Zealand 6.3, Germany 1.5, and England 0.9.
  • The most significant divergence was observed in 5- to 9-year-olds, with rates of USA 27, New Zealand 0.22, Australia 0.14, Germany 0.03, and England 0.00.
  • The disparity in US rates for paediatric bipolar disorder was notably greater than for overall child psychiatric diagnoses or adult bipolar disorder.

Conclusions:

  • A substantial disparity exists between US and other countries' discharge rates for paediatric bipolar disorder.
  • This significant variation suggests potential differences in diagnostic practices for paediatric bipolar disorder, particularly in the USA.
  • Further research is warranted to understand the drivers behind these international diagnostic variations.
Abstract

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
309
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
626
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.5K